Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Modulating testosterone pathway: a new strategy to tackle male skin aging?

Bernard P, Scior T, Do QT.

Clin Interv Aging. 2012;7:351-61. doi: 10.2147/CIA.S34034. Epub 2012 Sep 13.

2.

Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation.

Yamaguchi M, Arbiser JL, Weitzmann MN.

Int J Mol Med. 2011 Dec;28(6):1049-53. doi: 10.3892/ijmm.2011.786. Epub 2011 Aug 31.

PMID:
21887456
3.

Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.

Ma L, Chen J, Wang X, Liang X, Luo Y, Zhu W, Wang T, Peng M, Li S, Jie S, Peng A, Wei Y, Chen L.

J Med Chem. 2011 Oct 13;54(19):6469-81. doi: 10.1021/jm200830u. Epub 2011 Sep 8.

PMID:
21853991
4.

Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.

Singh T, Katiyar SK.

PLoS One. 2013 Apr 8;8(4):e60749. doi: 10.1371/journal.pone.0060749. Print 2013.

5.

Multiple effects of Honokiol on the life cycle of hepatitis C virus.

Lan KH, Wang YW, Lee WP, Lan KL, Tseng SH, Hung LR, Yen SH, Lin HC, Lee SD.

Liver Int. 2012 Jul;32(6):989-97. doi: 10.1111/j.1478-3231.2011.02621.x. Epub 2011 Aug 11.

PMID:
22098176
6.

Nitrogenated honokiol derivatives allosterically modulate GABAA receptors and act as strong partial agonists.

Bernaskova M, Schoeffmann A, Schuehly W, Hufner A, Baburin I, Hering S.

Bioorg Med Chem. 2015 Oct 15;23(20):6757-62. doi: 10.1016/j.bmc.2015.08.034. Epub 2015 Aug 28.

PMID:
26410663
7.

Honokiol trimers and dimers via biotransformation catalyzed by Momordica charantia peroxidase: novel and potent α-glucosidase inhibitors.

He Y, Wang XB, Fan BY, Kong LY.

Bioorg Med Chem. 2014 Jan 15;22(2):762-71. doi: 10.1016/j.bmc.2013.12.005. Epub 2013 Dec 11.

PMID:
24360831
8.

Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes.

Jeong HU, Kong TY, Kwon SS, Hong SW, Yeon SH, Choi JH, Lee JY, Cho YY, Lee HS.

Molecules. 2013 Sep 3;18(9):10681-93. doi: 10.3390/molecules180910681.

9.
10.

Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.

Kumar A, Kumar Singh U, Chaudhary A.

Future Med Chem. 2013 May;5(7):809-29. doi: 10.4155/fmc.13.32. Review.

PMID:
23651094
11.

Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.

Taferner B, Schuehly W, Huefner A, Baburin I, Wiesner K, Ecker GF, Hering S.

J Med Chem. 2011 Aug 11;54(15):5349-61. doi: 10.1021/jm200186n. Epub 2011 Jul 12.

PMID:
21699169
12.

Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.

Singh T, Katiyar SK.

Int J Oncol. 2011 Mar;38(3):769-76. doi: 10.3892/ijo.2011.899. Epub 2011 Jan 11.

PMID:
21225228
13.

Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.

Zhang X, Chen S, Wang Y.

Eur J Pharmacol. 2007 Jan 5;554(1):1-7. Epub 2006 Oct 10.

PMID:
17109844
14.

Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum.

Chan SS, Zhao M, Lao L, Fong HH, Che CT.

Planta Med. 2008 Mar;74(4):381-4. doi: 10.1055/s-2008-1034320.

PMID:
18484527
15.

Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes.

Chen YJ, Tsai KS, Chan DC, Lan KC, Chen CF, Yang RS, Liu SH.

J Orthop Res. 2014 Apr;32(4):573-80. doi: 10.1002/jor.22577. Epub 2013 Dec 27.

16.

Honokiol induces cell cycle arrest and apoptosis via inhibiting class I histone deacetylases in acute myeloid leukemia.

Li HY, Ye HG, Chen CQ, Yin LH, Wu JB, He LC, Gao SM.

J Cell Biochem. 2015 Feb;116(2):287-98. doi: 10.1002/jcb.24967.

PMID:
25187418
17.
18.

Magnolol and honokiol: inhibitors against mouse passive cutaneous anaphylaxis reaction and scratching behaviors.

Han SJ, Bae EA, Trinh HT, Yang JH, Youn UJ, Bae KH, Kim DH.

Biol Pharm Bull. 2007 Nov;30(11):2201-3.

19.

Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function.

Crane C, Panner A, Pieper RO, Arbiser J, Parsa AT.

J Immunother. 2009 Jul-Aug;32(6):585-92. doi: 10.1097/CJI.0b013e3181a8efe6.

20.

Supplemental Content

Support Center